Case Series of Bacteremia Associated with Probiotic Use in Children after Cardiac Surgery, China

https://wwwnc.cdc.gov/eid/article/32/1/25-0298_article

Effect of Chloramine Disinfection of Community Water System on Legionnaires’ Disease Outbreak, Minnesota, USA, 2024

https://wwwnc.cdc.gov/eid/article/32/1/25-1232_article

Sphingobacterium hotanense Infections in Immunocompromised Patients, United States

https://wwwnc.cdc.gov/eid/article/32/1/25-1290_article

A Tangle of Curious Forms

https://wwwnc.cdc.gov/eid/article/32/13/ac-3114_article

Emergence of New Delhi Metallo-β-Lactamase 14–Producing Klebsiella pneumoniae Sequence Type 147 Clone in Spain and Outbreak in the Canary Islands

https://wwwnc.cdc.gov/eid/article/32/1/25-1504_article

Disseminated Nocardia ignorata Infection with Splenic and Brain Involvement in Patient with Large B-Cell Lymphoma

https://wwwnc.cdc.gov/eid/article/32/1/25-1546_article

Detection of Oropouche and Punta Toro Virus Infections by Enhanced Surveillance, Panama, 2023–2024

https://wwwnc.cdc.gov/eid/article/32/1/25-1224_article

Emerging Respiratory Virus Threats from Influenza D and Canine Coronavirus HuPn-2018

https://wwwnc.cdc.gov/eid/article/32/1/25-1764_article

Mycobacterium decipiens Infection in Patient Receiving Anti–TNF-α Therapy, France, 2024

https://wwwnc.cdc.gov/eid/article/32/1/25-0518_article

Detection of Novel Thermotolerant Tepidimonas sp. Bacteria in Human Respiratory Specimens, Hong Kong, China, 2024

https://wwwnc.cdc.gov/eid/article/32/1/25-0818_article

Evidence of Rat Hepatitis E Virus Circulation through Wastewater Surveillance, Central Argentina

https://wwwnc.cdc.gov/eid/article/32/1/25-1218_article

Group A Streptococcus Meningitis, United States, 1997–2022

https://wwwnc.cdc.gov/eid/article/32/1/25-0871_article

[Newsdesk] Highlights from ASTMH 2025
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00007-1/fulltext?rss=yes

Between Nov 9 and Nov 13, Toronto, Canada, hosted the 74th Annual Meeting of the American Society of Tropical Medicine & Hygiene. Marco De Ambrogi reports.

[Newsdesk] Research in brief
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00017-4/fulltext?rss=yes

In a cross-sectional serological study, researchers in Brazil examined the persistence of protective Zika virus neutralising antibodies in women infected during pregnancy and in their children exposed in utero. In blood serum samples obtained from 77 women with confirmed Zika virus infection during pregnancy, 66·2% had detectable Zika virus neutralising antibodies above the cutoff point around 45·7 weeks after gestational infection, with mean titres of 1559·2 (SD 4598·4). First-trimester infection significantly increased the likelihood of persistent maternal antibodies beyond 45 weeks compared with second-trimester infection (odds ratio [OR] 4·72, 95% CI 1·11–35·8).

[Profile] Katie Anders—improving global dengue control
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00012-5/fulltext?rss=yes

Katherine (Katie) Anders grew up in an academic home in Melbourne, VIC, Australia with a malariologist father and an immunologist mother. “Discussions about human biology and disease, health inequities, and advances in medical science were standard meal-time conversations at our house: it was subliminal exposure to a scientific way of thinking from an early age”, Anders told The Lancet Infectious Diseases. And while she initially resisted an academic career path, an interest in medicine and science was always there.

[Newsdesk] CDC cuts to childhood vaccine recommendations
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00014-9/fulltext?rss=yes

New childhood vaccine recommendations from the US Centers for Disease Control and Prevention have been widely criticised by experts. Priya Venkatesan reports.

[Newsdesk] Brazil approves domestic single-shot dengue vaccine
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00013-7/fulltext?rss=yes

In December 2025, the domestically produced Butantan-DV vaccine was approved by Brazil's regulatory agency for use in individuals aged 12–59 years. Marcia Triunfol reports.

Retrospective Case Series of Ocular Lyme Disease, 1988–2025

https://wwwnc.cdc.gov/eid/article/32/1/25-0769_article

Retail Milk Monitoring of Influenza A(H5N1) in Dairy Cattle, United States, 2024–2025

https://wwwnc.cdc.gov/eid/article/32/2/25-1332_article

[Comment] Lessons from Brazil's elimination of vertical HIV transmission
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00002-0/fulltext?rss=yes

In 2025, WHO's validation of Brazil for the elimination of vertical transmission of HIV (sometimes referred to as mother-to-child transmission of HIV) is a landmark global public health achievement.1 As the most populous country to reach this milestone, Brazil shows that elimination is feasible even in large, socially diverse, and unequal settings when political commitment, universal health coverage, and human rights are placed at the centre of health policy.1 This success highlights the urgency for countries in sub-Saharan Africa to implement concrete, scalable, and equity-oriented strategies to achieve similar progress in eliminating vertical transmission of HIV.

[Articles] Acceptability and tolerability of long-acting injectable cabotegravir–rilpivirine in adolescents with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multicentre, open-label, non-comparative phase 1/2 trial
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00241-3/fulltext?rss=yes

Acceptability and tolerability of intramuscular cabotegravir–rilpivirine remained high through to 48 weeks of treatment, suggesting that this long-acting intramuscular treatment approach is well received by diverse populations of adolescents with HIV across multiple settings.